Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.
Original statement
حتى أكبر تجربة طويلة الأمد (SOS) أظهرت أن مرضى الجراحة يموتون قبل عامة السكان بـ 5.5 سنوات.
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.
Origin
- Source status
- Archive editors
- Attribution
- Archive editors (eltayebat.com); not necessarily Elawady's own words
- Origin
- https://eltayebat.com/rule/bariatric-surgery/
- Attribution uncertainty
- Editorial summary/narrative and study selection written by the archive operators; the archive states that the cited research documents harm independently of Dr. Diaa's words.
- Claimed mechanism
Implied: surgery does not restore normal survival.
- Claimed health effect
Shorter life than general population.
- Population concerned
SOS participants
- Geographic restriction by Elawady
not applicable
Scientific assessment
Mostly true – Correct at its core, but with limitations or minor inaccuracies.
Certainty of evidence: high – Further research is very unlikely to change the assessment.
1. What was claimed?
SOS patients die 5.5 years earlier than the general population.
2. What is demonstrably correct?
Correct: adjusted median life expectancy in the surgery group was 5.5 years shorter than in the general population, and 3.0 years longer than in usual care (A-BAR-05).
3. What is wrong or exaggerated?
Read alone, the summary suggests surgery shortens life. The full text shows the non-operated obesity group had an 8.5-year shorter life expectancy; surgery reduced the gap. The authors attribute the remaining gap to persistent above-normal BMI, irreversible metabolic damage, surgical complications and other causes (alcoholism, suicide, trauma).
4. What remains unclear?
Whether modern procedures narrow the gap more.
5. Which studies support it?
A-BAR-05; Nordic registry confirms operated patients still have about twice the general-population mortality (SMR 1.94, I-BAR-104).
6. Which studies contradict it?
A-BAR-05 (full context), I-BAR-01, I-BAR-10; I-BAR-104 (all-cause HR 0.63 vs obese non-operated people); I-BAR-106 (16% lower mortality over up to 40 years).
7. What applies to Germany and Europe?
Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.
8. What is known about Egypt?
No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.
9. What practical conclusion is appropriate?
Bariatric surgery improves but does not normalize life expectancy in severe obesity.
Assessment details
- Rationale for certainty of evidence
Number directly reported in the NEJM abstract and full text; interpretation issue only.
- Source quality
The number is correct. The summary omits that controls lived about 8.5 years less than the general population, so surgery narrowed the gap by 3 years; SOS is a non-randomized controlled study, not a randomized 'trial'. The narrative and featured card report both numbers correctly.
- Regional transferability
Swedish data.
- Individual exceptions
Not applicable.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
Scientifically well supported – The claim agrees with consistent, high-quality evidence.
Research question: In the SOS study, did surgery patients die about 5.5 years earlier than the general population, and does this mean surgery shortens life?
Research question in detail (PICO)
- Population
- SOS participants with obesity
- Intervention or exposure
- Bariatric surgery
- Comparison
- General population; matched obese usual-care controls
- Geographic scope
- universal (Swedish data)
- Outcomes
- Life expectancy
- Standardised mortality
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
Swedish 24-year study: surgery added about 3 years of life
Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449 Cohort studyfull text checkedSOS: life expectancy after surgery 5.5 years shorter than general population.
- Actual result
- -5.5 years (3.4-7.6) vs general population; +3.0 years vs usual care.
- Methodological quality
- moderate-high
- Relevance
- direct
- Limitations
- Non-randomised
Nordic study: survival after obesity surgery
Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048 Cohort studyabstract checkednewly addedNordic registry: operated patients still have about twice the general-population mortality.
- Actual result
- SMR 1.94 (1.83-2.05).
- Methodological quality
- moderate
- Relevance
- direct for the number
- Limitations
- Registry
What speaks against the claim?
Swedish 24-year study: surgery added about 3 years of life
Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449 Cohort studyfull text checkedSame study: usual-care controls lived 8.5 years less than the general population; surgery narrowed the gap.
- Actual result
- +3.0 years vs controls.
- Methodological quality
- moderate-high
- Relevance
- direct - contradicts the implied causal message
- Limitations
- Non-randomised
Meta-analysis: weight-loss surgery and survival
Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2 Meta-analysisabstract checkedMeta-analysis: +6.1 years median life expectancy vs matched controls.
- Actual result
- HR ~0.51.
- Methodological quality
- moderate-high
- Relevance
- direct
- Limitations
- Observational
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
The 5.5-year figure is correct; the remaining gap reflects severe obesity and its consequences, not harm from surgery.
Why some studies weigh more
Same primary source for both readings; Nordic registry confirms the pattern.
Is a causal relationship established? Not applicable The claim reports a descriptive number.
Remaining uncertainty
Whether modern procedures narrow the gap further.
Justified conclusion
Number correct; implied conclusion misleading.
Why do studies seem to disagree?
None: comparisons with the general population and with obese controls answer different questions (see C-BAR-01).
Does this depend on the country?
- General biological effects
- Universal.
- Eating habits
- Not applicable (surgical procedure, not a food).
- Origin of the food
- Not applicable (surgical procedure, not a food).
- Contaminants
- Not applicable (surgical procedure, not a food).
- National production conditions
- Not applicable.
- Legal rules
- Not applicable.
- Actual monitoring data
- Not applicable.
A regional difference that changes the conclusion is not supported by robust data.
Statistical re-check
- Life-years gained and share of gap closed – 8.5 - 5.5 = 3.0 years gained (matches report); about 35% of the obesity-related gap closed. recalculated
- SMR CI symmetry – Consistent. recalculated
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- Life expectancy after surgery vs general population (descriptive)
- Starting level
- low (observational studies)
- Reasons for upgrading
- consistency
- large precise registry data
- Result
- high
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| Europe PMC | 26 October 2026 | (TITLE:"bariatric" OR TITLE:"sleeve gastrectomy" OR TITLE:"metabolic surgery") AND (TITLE:"mortality" OR TITLE:"survival" OR TITLE:"life expectancy") AND (PUB_TYPE:"Meta-Analysis" OR TITLE:"meta-analysis") AND PUB_YEAR:[2019 TO 2026] | both directions | 14 | |
| PubMed | 26 October 2026 | (bariatric surgery[tiab] OR sleeve gastrectomy[tiab]) AND (increased mortality[ti] OR excess mortality[ti] OR "mortality" [ti]) AND (external causes OR suicide OR accidents OR younger OR late mortality) | supporting evidence | 43 |
Open questions
None beyond C-BAR-01.
How deeply was this checked?
5 linked studies: 3 checked in full text (1 of them with a structured risk-of-bias assessment), 2 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: Mostly true (high)
- 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: Mostly true (high)
Unchanged (“Mostly true”, high). Nordic registry data (I-BAR-104) and Utah 40-year data (I-BAR-106) confirm the pattern.
New sources: I-BAR-104 I-BAR-106
In plain language
The archive says that even after surgery, Swedish patients died about 5.5 years earlier than the general population. The number is correct. But the same study shows that people with obesity who did not have surgery lived about 8.5 years less than the general population. Surgery therefore added about 3 years of life; it did not cause the remaining gap. Severe obesity itself shortens life.
Studies on this claim
Studies supporting the claim (2)
-
Swedish 24-year study: surgery added about 3 years of life
Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449Cohort studycited by the Tayebat archivefull text checked★ key studyOperated patients lived about 3 years longer than non-operated patients with obesity, but still about 5.5 years less than the general population (non-operated: about 8.5 years less).
Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Life expectancy
- How was the study done?
Prospective controlled cohort with population reference
- How many people, animals or samples were studied?
5182 people
- What was actually found?
Surgery gained 3 years; gap to population 5.5 vs 8.5 years
- How large was the observed effect?
HR death 0.77; +3.0 years
- What do the results mean in everyday life?
Surgery reduced but did not remove the life-expectancy loss linked to severe obesity
- What are the study's limitations?
Not randomized; old operations
- What does it say about Elawady's specific claim?
Number correct, implication 'surgery shortens life' wrong
- Do the results apply to Germany and Europe?
Directly European
- What can explicitly not be concluded from this study?
That surgery causes the remaining 5.5-year gap
-
Nordic study: survival after obesity surgery
Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048Cohort studyindependent cross-checkabstract checked★ key studyOperated people died less often than non-operated people with obesity, but more often than the general population; suicide deaths were more frequent.
Confirms operated patients still die earlier than the general population (SMR ~1.9).
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Compare survival with two reference groups
- How was the study done?
Registry cohort
- How many people, animals or samples were studied?
505,258 (49,977 operated)
- What was actually found?
HR 0.63 vs obese; SMR 1.94 vs general population
- How large was the observed effect?
All-cause HR 0.63; suicide HR 1.68
- What do the results mean in everyday life?
Surgery reduces but does not remove the excess risk of obesity
- What are the study's limitations?
Older procedures; registry data
- What does it say about Elawady's specific claim?
Contradicts "lethal", supports "still shorter life than general population"
- Do the results apply to Germany and Europe?
Direct European data
- What can explicitly not be concluded from this study?
Sleeve-specific long-term effects
No study in this group is marked as key.
Studies contradicting or limiting the claim (2)
-
Meta-analysis: weight-loss surgery and survival
Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2Meta-analysisindependent cross-checkabstract checked★ key studyAcross 174,772 people, surgery was linked to about half the risk of death and about 6 more years of median life expectancy; sleeve showed similar effects to bypass.
Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Survival
- How was the study done?
Meta-analysis of matched cohorts
- How many people, animals or samples were studied?
174,772
- What was actually found?
Lower mortality
- How large was the observed effect?
HR ~0.51; +6.1 years
- What do the results mean in everyday life?
Surgery is linked to longer, not shorter, life in severe obesity
- What are the study's limitations?
Observational studies
- What does it say about Elawady's specific claim?
Contradicts 'lethal'
- Do the results apply to Germany and Europe?
Includes Europe
- What can explicitly not be concluded from this study?
Exact causal size
-
Body weight and death risk worldwide
Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1Meta-analysisindependent cross-checkfull text, structured risk-of-bias assessmentSevere obesity (BMI 40+) was linked to nearly 3 times the death risk of normal weight.
Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
BMI-mortality
- How was the study done?
IPD meta-analysis
- How many people, animals or samples were studied?
~4 million
- What was actually found?
Higher BMI, higher mortality
- How large was the observed effect?
HR 2.76 grade 3
- What do the results mean in everyday life?
Severe obesity itself shortens life
- What are the study's limitations?
Observational
- What does it say about Elawady's specific claim?
Context for SOS gap
- Do the results apply to Germany and Europe?
Includes Europe
- What can explicitly not be concluded from this study?
Effect of weight loss
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
40-year Utah study: deaths after weight-loss surgery
Adams et al.. Obesity (Silver Spring) 2023 · PMID 36695060 · DOI 10.1002/oby.23646Cohort studyindependent cross-checkfull text checked★ key studyOverall deaths were 16% lower after surgery, but suicide was about 2.4 times more frequent, mostly in young patients.
Overall mortality 16% lower vs matched non-surgical persons.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Long-term mortality by procedure and age
- How was the study done?
Matched cohort
- How many people, animals or samples were studied?
21,837 pairs
- What was actually found?
Lower all-cause, CVD, cancer, diabetes deaths; more suicide
- How large was the observed effect?
HR 0.84; suicide HR 2.4
- What do the results mean in everyday life?
Benefit overall, specific mental-health risk
- What are the study's limitations?
Self-reported control BMI
- What does it say about Elawady's specific claim?
Confirms suicide risk; contradicts general life-shortening
- Do the results apply to Germany and Europe?
Transferable
- What can explicitly not be concluded from this study?
Causation
No study in this group is marked as key.
Regional context
Germany / EU
Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.
Egypt
No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.
What applies in my country?
General scientific assessment
Mostly true Correct number, but surgery narrowed the gap rather than causing it.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study.. Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449
- Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study.. Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048
- Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.. Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.. Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1
- Long-term all-cause and cause-specific mortality for four bariatric surgery procedures.. Adams et al.. Obesity (Silver Spring) 2023 · PMID 36695060 · DOI 10.1002/oby.23646